Mr. John Connaghan:

I have already provided some information on Scally.

I will just deal with HPV. I briefed the committee at the previous session on the four parts of the critical part that we need to put in place around HPV introduction. We need to get this absolutely right. It is so important for the women of Ireland that we do not want to rush on it.

One can understand our national caution about pitching something to the committee here that says we will promise to have this in by October, and that does not materialise. I would be back in front of the committee being asked about what went wrong.

It may well be that we are able to get something in sooner rather than later if our position on a negotiated contract with some of the laboratories that are interested in doing this are more fruitful in the short term rather than the long term, but we will take out the tendering process and tender evaluation part of that.

I hope we will have a clinical director next week who we can put into this full time to be able to take the service specification and make sure it is fine from a clinical point of view. That is one of the key steps we need to put in place.

I am reluctant to give an answer at this stage until I have an appropriate critical path in front of me. The Deputy can understand that.